The "NBAS Gene Short Stature Optic Nerve Atrophy and Pelger-Huet Anomaly Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the NBAS gene. These mutations are associated with a rare condition characterized by a constellation of symptoms including short stature, optic nerve atrophy, and Pelger-Huët anomaly - an abnormality in white blood cells. The test plays a crucial role in the early identification and management of affected individuals, providing essential information for healthcare providers to devise appropriate treatment and management plans. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test ensures accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the results.
The PIK3R1 Gene Short Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PIK3R1 gene. This gene plays a crucial role in various cellular processes, including growth, proliferation, and metabolism. Mutations in the PIK3R1 gene can lead to a spectrum of disorders, collectively referred to as PIK3R1-related short syndrome. This condition is characterized by short stature, insulin resistance, and an increased risk of developing diabetes and other metabolic issues.
The test is conducted using a sample of the patient's DNA, obtained through a simple and non-invasive procedure. It aims to provide conclusive evidence of the presence or absence of genetic mutations associated with the syndrome, offering valuable information for diagnosis, management, and treatment planning.
Priced at 4400 AED, the PIK3R1 Gene Short Syndrome Genetic Test at DNA Labs UAE is a crucial investment for individuals experiencing symptoms or with a family history of the condition. It empowers patients and healthcare providers with the knowledge needed to make informed decisions regarding health and lifestyle, potentially improving the quality of life for those affected by the syndrome.
The RDH11 gene is associated with a rare genetic disorder characterized by a triad of clinical features: retinal dystrophy, juvenile cataracts, and short stature. This condition is inherited in an autosomal recessive pattern, meaning that individuals must receive a mutated gene from each parent to be affected. The RDH11 gene plays a crucial role in the visual cycle and the metabolism of retinoids, which are compounds essential for vision and overall growth. Mutations in this gene disrupt these processes, leading to the development of the associated symptoms.
To diagnose this condition, a genetic test targeting the RDH11 gene can be conducted. This test involves analyzing the DNA to identify mutations in the RDH11 gene that are known to cause the syndrome. It is a critical step for families seeking answers for their loved ones showing symptoms consistent with this syndrome, as a definitive genetic diagnosis can guide management and treatment strategies.
In the UAE, this specific genetic test is available at DNA Labs UAE, a facility equipped with advanced genetic testing technologies. The cost of the RDH11 gene test is 4400 AED. Opting for this test at DNA Labs UAE ensures a comprehensive analysis by experienced geneticists, providing families with accurate and actionable insights into their genetic health. This test not only aids in the diagnosis but also helps in understanding the risk of passing the condition to future generations, facilitating informed decisions regarding family planning.
The MECP2 gene Rett Syndrome genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MECP2 gene, which are closely associated with Rett Syndrome. Rett Syndrome is a rare genetic neurological disorder that primarily affects females, leading to severe cognitive and physical impairments shortly after birth. The test is crucial for early diagnosis, enabling timely intervention and management of the condition. Priced at 4400 AED, this genetic test provides families and healthcare providers with essential genetic insights, facilitating a better understanding of the condition and paving the way for personalized treatment plans. DNA Labs UAE employs cutting-edge genetic testing technologies to ensure accurate and reliable results, making it a trusted choice for those seeking comprehensive genetic analysis related to Rett Syndrome.
The "FOXG1 Gene Rett Syndrome Congenital Variant Genetic Test" is a specialized diagnostic tool designed to identify mutations in the FOXG1 gene, which are known to cause the congenital variant of Rett Syndrome. Rett Syndrome is a rare, genetic neurological disorder that primarily affects females, leading to severe cognitive and physical impairments shortly after birth. The congenital variant, linked to mutations in the FOXG1 gene, manifests with similar but distinct symptoms, including developmental delays, challenges in motor skills, and intellectual disabilities.
This genetic test is crucial for early diagnosis and management of the condition, allowing for tailored therapies and interventions that can improve the quality of life for affected individuals. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and reliability in results. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.
By opting for this test, families and healthcare providers can gain valuable insights into the genetic underpinnings of the patient's condition, paving the way for a better understanding and more effective management of Rett Syndrome's congenital variant.
The GNPAT Gene Rhizomelic Chondrodysplasia Punctata Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GNPAT gene, which are linked to Rhizomelic Chondrodysplasia Punctata Type 2 (RCDP2). RCDP2 is a rare genetic disorder characterized by shortening of the bones in the upper arms and thighs (rhizomelia), distinctive facial features, and severe intellectual disabilities, among other symptoms. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two mutated copies of the GNPAT gene to be affected.
This test is critical for accurate diagnosis, enabling targeted interventions and management strategies to improve the quality of life for affected individuals. The test is conducted through a blood sample or cheek swab, which is then analyzed for specific genetic alterations associated with RCDP2. At a cost of 4400 AED, the GNPAT Gene Test is an invaluable tool for families seeking answers to complex genetic conditions, providing them with the necessary information to understand their genetic health better and make informed decisions about their care.
The AGPS Gene Rhizomelic Chondrodysplasia Punctata Type 3 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the AGPS gene. This gene plays a critical role in the development and function of peroxisomes, cellular structures that are essential for the body's metabolic processes. Mutations in the AGPS gene are associated with Rhizomelic Chondrodysplasia Punctata Type 3 (RCDP3), a rare genetic disorder characterized by skeletal abnormalities, specific facial features, and intellectual disability, among other symptoms.
The test is aimed at individuals who are suspected to have RCDP3, based on clinical evaluation, or those who have a family history of the condition and are considering genetic counseling. By analyzing the patient's DNA, the test can confirm the presence of AGPS gene mutations, providing crucial information for diagnosis, management, and treatment planning.
The cost of the AGPS Gene Rhizomelic Chondrodysplasia Punctata Type 3 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and specificity of the test, it represents a significant step forward in the genetic diagnosis of this rare condition, offering hope for affected individuals and their families for better-informed healthcare decisions.
The PEX5 Gene Rhizomelic Chondrodysplasia Punctata Type 5 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the PEX5 gene, which are linked to Rhizomelic Chondrodysplasia Punctata Type 5 (RCDP5). RCDP5 is a rare genetic disorder characterized by skeletal abnormalities, shortening of the proximal limbs (rhizomelia), distinctive facial features, and intellectual disability, among other symptoms. The condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the PEX5 gene that are responsible for the disorder. This genetic test is crucial for accurate diagnosis, allowing for appropriate management and treatment plans tailored to the patient's specific needs. Additionally, it can provide valuable information for family planning and genetic counseling for families affected by RCDP5.
At DNA Labs UAE, the PEX5 Gene Rhizomelic Chondrodysplasia Punctata Type 5 Genetic Test is offered at a cost of 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify mutations in the PEX5 gene and interpret the results in the context of the patient's health and family history.
The WASHC5 gene, associated with Ritscher-Schinzel Syndrome Type 1, plays a crucial role in this rare genetic disorder characterized by congenital heart defects, cerebellar abnormalities, and distinctive facial features. A genetic test for identifying mutations in the WASHC5 gene can provide definitive diagnosis and is crucial for understanding the risk of passing the condition to offspring, guiding medical management, and offering tailored care to affected individuals.
DNA Labs UAE offers a specialized genetic test for the WASHC5 gene to diagnose Ritscher-Schinzel Syndrome Type 1. The test is priced at 4400 AED and involves analyzing the patient's DNA to detect mutations in the WASHC5 gene that are indicative of the syndrome. This precise testing method is vital for families seeking answers to developmental and health concerns related to this condition. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect accurate, reliable results that are essential for informed decision-making regarding treatment and genetic counseling.
The HNRNPU Gene RNA Processing Related Disorders Genetic Test is a specialized diagnostic examination designed to identify mutations in the HNRNPU gene, which is crucial for proper RNA processing in the human body. Abnormalities in this gene have been linked to a range of developmental and neurological disorders, making early detection vital for effective management and treatment strategies. The test involves analyzing the patient's DNA to pinpoint any genetic alterations in the HNRNPU gene that could disrupt normal RNA processing and lead to associated health issues.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis with state-of-the-art technology to ensure accurate and reliable results. The cost of the test is set at 4400 AED, reflecting the intricate processes and expert analysis involved in identifying the genetic variations linked to these complex disorders. By opting for this test, patients and their families can gain crucial insights into their genetic makeup, paving the way for personalized medical care and interventions tailored to their specific genetic profile.
